RE: Market Capitalisation of CPX18 Jul 2024 11:58
L1onheart; many thanks, that's exactly the post I was looking for and thank you for adding some extra comments at the end. Interesting to note that the MCap has been nearly 6x what it is today... DDx
"Hi Della, that was me (full post 12:23h today):
March 2019 - SP 7.50p / MCAP £24m / Shares 324m
Dec 2020 - SP 13.75p / MCAP £62.7m / Shares 456m (Last 5 year High)
Feb 2021 - SP 10.50p / MCAP £47m / Shares 456m
May 2022 - SP 4.70p / MCAP £23.50m / Shares 509m
Dec 2022 - SP 3.80p / MCAP £19.50m / Shares 510m (Target Valuation - 14p or £71m)
Dec 2023 - SP 1.70p / MCAP £12m / Shares 716m (Just before Maxwell loss) - (TV 7p or £50m)
Dec 2023 - SP 0.75p / MCAP £5.4m / Shares 716m (Immediately after Maxwell loss)
Mar 2024 - SP 0.50p / MCAP £3.6m / Shares 716m
May - SP 0.083p / MCAP £2.38m / Shares 2,910m
Today - SP 0.40p / MCAP £11.78m / Shares 2,910m
Much of the fall from 14p was a 3%+ holder, David Newlands, who had bought all the way up from 4p many years ago and then sold all the way down so the sp and therefore obviously the MCAP, fell significantly. However, even then, it was still double today in late 2022 on much thinner fundamentals. The Maxwell loss then torpedoed the sp and also created the need for cash which, as sp was so dire, meant a huge dilution from 716m to 4x times that at 2,910m now in issue. A sp of just 1p would now be a modest MCAP of £29m, if you consider where we have been as recently as 18 months ago and that was without Dr Cooley, his 10% or his experienced colleagues joining the board. It does look like a genuine recovery with still some way to go by any metric you care to choose. GLA